Digital Pharma is running out of names. Can an AI help? At Reuters Pharma USA, presenters showed off an AI aimed at reimagining the complex process of pharmaceutical naming.
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
